BindingDB logo
myBDB logout

9 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
11140732 10 Antimitotic and cell growth inhibitory properties of combretastatin A-4-like ethers.EBI Department of Chemistry, UMIST, Manchester, UK. lawrencenj1@cardiff.ac.uk
9873473 4 Asymmetric synthesis of antimitotic combretadioxolane with potent antitumor activity against multi-drug resistant cells.EBI Institute of Molecular and Cellular Biosciences (IMCB), University of Tokyo, Japan.
27149641 5 Synthesis, Evaluation, and Mechanism Study of Novel Indole-Chalcone Derivatives Exerting Effective Antitumor Activity Through Microtubule Destabilization in Vitro and in Vivo.EBI Sun Yat-sen University
26970659 3 Design, synthesis of phenstatin/isocombretastatin-oxindole conjugates as antimitotic agents.EBI CSIR-Indian Institute of Chemical Technology
26927488 4 Discovery of novel 2-phenyl-imidazo[1,2-a]pyridine analogues targeting tubulin polymerization as antiproliferative agents.EBI Shanghai Institute of Materia Medica
27066215 3 Synthesis and anti-cancer screening of novel heterocyclic-(2H)-1,2,3-triazoles as potential anti-cancer agents.EBI University of Arkansas for Medical Sciences
26204510 6 4-Fluoro-3',4',5'-trimethoxychalcone as a new anti-invasive agent. From discovery to initial validation in an in vivo metastasis model.EBI Ghent University
25108078 13 Synthesis and biological evaluations of new analogs of 2-methoxyestradiol: inhibitors of tubulin and angiogenesis.EBI University of Oslo
25313318 4 Development of a new benzophenone-diketopiperazine-type potent antimicrotubule agent possessing a 2-pyridine structure.EBI Tokyo University of Pharmacy and Life Sciences